Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-18-000388

Options or other derivatives

  • Director acquired 32,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MENDLEIN JOHN · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Grant or award : show line 1 in the form Stock Option (right to buy) +32,000 32,000 D
Loading xslF345X03/doc4.xml…